A Multicentre, Randomised, Open-Label Study To Compare The Efficacy And Safety Of Azithromycin For 5 Days With Those Of Amoxicillin-Clavulanic Acid In Patients With Chronic Bronchitis

NCT00649831 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

250

Enrollment

INDUSTRY

Sponsor class

Conditions

Bronchitis, Chronic

Interventions

DRUG: Amoxicillin/clavulinic acid
DRUG: Azithromycin

Sponsor

Pfizer